0001104659-21-025273.txt : 20210218 0001104659-21-025273.hdr.sgml : 20210218 20210218165706 ACCESSION NUMBER: 0001104659-21-025273 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210216 FILED AS OF DATE: 20210218 DATE AS OF CHANGE: 20210218 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hesslein Robert W. CENTRAL INDEX KEY: 0001585018 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37625 FILM NUMBER: 21650361 MAIL ADDRESS: STREET 1: C/O FOUNDATION MEDICINE, INC. STREET 2: ONE KENDALL SQUARE, SUITE B3501 CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Voyager Therapeutics, Inc. CENTRAL INDEX KEY: 0001640266 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 75 SIDNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 857-259-5340 MAIL ADDRESS: STREET 1: 75 SIDNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 tm217191-2_4seq1.xml OWNERSHIP DOCUMENT X0306 4 2021-02-16 0 0001640266 Voyager Therapeutics, Inc. VYGR 0001585018 Hesslein Robert W. C/O VOYAGER THERAPEUTICS, INC. 75 SIDNEY STREET CAMBRIDGE MA 02139 0 1 0 0 Senior VP & General Counsel Common Stock 2021-02-16 4 A 0 34000 0 A 83348 D Stock Option (Right to Buy) 7.33 2021-02-16 4 A 0 68000 0 A 2031-02-16 Common Stock 68000 68000 D Consists of shares of common stock issuable under an aggregate of 34,000 restricted stock units ("RSUs") awarded to the Reporting Person pursuant to the Voyager Therapeutics, Inc. 2015 Stock Option and Incentive Plan (the "Plan"). Each RSU represents the right to receive one share of common stock upon vesting. The vesting commencement date of the RSU award is the grant date, February 16, 2021. The RSU award vests over three years, with 1/3rd of the shares of common stock underlying the RSU award vesting on the one-year anniversary of such vesting commencement date and an additional 1/3rd of the shares of common stock underlying the RSU award vesting at the end of each successive one-year period thereafter, subject to the Reporting Person's continued service. This stock option was issued pursuant to the Plan. The vesting commencement date of the option is the grant date, February 16, 2021. The option vests over four years, with 1/48th of the shares of common stock underlying the option vesting upon the one-month anniversary of such vesting commencement date and an additional 1/48th of the shares of common stock underlying the option vesting at the end of each successive one-month period thereafter, subject to the Reporting Person's continued service. /s/ Allison Dorval, as Attorney-in-Fact for Robert W. Hesslein 2021-02-18